(EMAILWIRE.COM, February 19, 2018 ) Industry Insights:

In this report, the global healthcare analytical testing services market is segmented on the basis of services, samples, end users, and regions. On the basis of services, the market is further segmented into bioanalytical testing, physical characterization, method validation, raw materials testing, stability testing, batch-release testing, microbial testing, and environmental monitoring services. The bioanalytical testing segment accounted for the largest share of the market in 2015, owing to the increased usage and development of macromolecules and biosimilars by biopharmaceutical companies.

Based on sample types, the healthcare analytical testing services market is segmented into raw materials, in-process samples, finished products, and environmental samples. Similarly, on the basis of end-users, the market is segmented into pharmaceutical and biopharmaceutical companies, medical device companies, and contract research organizations.

Get The PDF Brochure For This Report:
https://www.marketsandmarkets.com/pdfdownload.asp?id=108923833

Geographical Scenario:

Geographically, the global healthcare analytical testing services market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded a major share of the market. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the large pool of pharmaceutical and biopharmaceutical companies, increasing government support from both an economic and policy standpoint to drive innovation in life sciences, and rapidly increasing demand for outsourcing of analytical testing.

Some of the prominent players in the global healthcare analytical testing services market include Exova Group Plc. (U.K.), Eurofins Scientific SE (Luxembourg), PPD Inc. (U.S.), WuXi PharmaTech (Cayman) Inc. (China), SGS (Switzerland), Charles River Laboratories International Inc. (U.S.), Source BioScience Plc. (U.K.), Anabiotec (Belgium), Intertek Group Plc. (U.K.), Medistri SA (Switzerland), Pace Analytical Services Inc. (U.S.), and BioReliance Corporation (U.S.).

Target Audience:
• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Medical Device Manufacturing Companies
• Government Associations
• Market Research and Consulting Firms
• Venture Capitalists and Investors

Request a sample of the report:
https://www.marketsandmarkets.com/requestsample.asp?id=108923833


Industry Leaders:

The market is led by Eurofins Scientific SE (Luxembourg), WuXi PharmaTech (Cayman) Inc. (China), SGS (Switzerland), and Charles River Laboratories International Inc. (U.S.). Other players in this market are PPD Inc. (U.S.), Exova Group Plc. (U.K.), Source BioScience Plc (U.K.), Intertek Group Plc. (U.K.), Medistri SA (Switzerland), Pace Analytical Services Inc. (U.S.), Anabiotec (Belgium), and BioReliance Corporation (U.S.).